TGFBR1 and colonic neoplasm: In an early-intervention setting, in which mice are treated from 85 days after induction, inhibition of ALK5 resulted in rapid development of highly invasive (T3) colonic tumors, although with markedly reduced metastasis (Figures 8B and 8C; Table S1).